| scholarly article | Q13442814 |
| P50 | author | Emily Herrett | Q117276796 |
| Jennifer K Quint | Q44802756 | ||
| P2093 | author name string | A Timmis | |
| H Hemingway | |||
| L Smeeth | |||
| K Bhaskaran | |||
| J A Wedzicha | |||
| P2860 | cites work | Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction | Q84579203 |
| Cardioselective beta-blockers for chronic obstructive pulmonary disease | Q24245649 | ||
| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary | Q29614692 | ||
| Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease | Q29618681 | ||
| Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care | Q33703602 | ||
| Chronic obstructive pulmonary disease after myocardial infarction in the community | Q33964930 | ||
| A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. | Q34567560 | ||
| Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study | Q34966373 | ||
| Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease | Q35534824 | ||
| The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study | Q36009093 | ||
| The Myocardial Ischaemia National Audit Project (MINAP). | Q36421825 | ||
| Mortality in COPD: Role of comorbidities. | Q36670236 | ||
| Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease | Q36883464 | ||
| Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions | Q37082599 | ||
| Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes | Q42610118 | ||
| Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease | Q43598623 | ||
| Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma | Q43636298 | ||
| Increased risk of myocardial infarction and stroke following exacerbation of COPD. | Q46731950 | ||
| Smoking and lung function of Lung Health Study participants after 11 years. | Q51705571 | ||
| Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. | Q52949846 | ||
| Chronic obstructive pulmonary disease and the risk of cardiovascular diseases | Q57950749 | ||
| Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease | Q57955820 | ||
| Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction | Q77109820 | ||
| Risk indexes for exacerbations and hospitalizations due to COPD | Q79546220 | ||
| Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction | Q79761190 | ||
| Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes | Q79817388 | ||
| Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD | Q81472072 | ||
| Can beta-blockers be used for people with COPD? | Q83160812 | ||
| P433 | issue | nov22 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | f6650 | |
| P577 | publication date | 2013-11-22 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records | |
| P478 | volume | 347 |
| Q37103385 | Acute exacerbation of COPD: is it the "stroke of the lungs"? |
| Q98180413 | Are We Treating Heart Failure in Patients with Chronic Obstructive Pulmonary Disease Appropriately? |
| Q54597749 | Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk My |
| Q47123558 | Beta-blocker under-use in COPD patients |
| Q39215564 | Beta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac disease |
| Q47746323 | Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD. |
| Q38944856 | Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care |
| Q55381292 | Chronic obstructive pulmonary disease and acute myocardial infarction: effects on presentation, management, and outcomes. |
| Q38342003 | Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management |
| Q50064555 | Chronic obstructive pulmonary disease and β-blocker treatment in Asian patients with heart failure |
| Q28646419 | Closing the mortality gap after a myocardial infarction in people with and without chronic obstructive pulmonary disease |
| Q47651592 | Defining the relationship between COPD and CVD: what are the implications for clinical practice? |
| Q33552577 | Effect of β-blockade on lung function, exercise performance and dynamic hyperinflation in people with arterial vascular disease with and without COPD. |
| Q33552609 | Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study |
| Q26764891 | Exacerbations of COPD |
| Q35168749 | Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease |
| Q91779597 | Ischemic Heart Disease during Acute Exacerbations of COPD |
| Q47098529 | Measuring cardiovascular risk in COPD; child's play or MENSA? |
| Q26741051 | Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease |
| Q40771974 | Pharmacological Management of Elderly Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation? |
| Q28566503 | Prescription of renin-angiotensin system blockers and risk of acute kidney injury: a population-based cohort study |
| Q36341776 | Presentation, management and mortality after a first MI in people with and without asthma: A study using UK MINAP data |
| Q39069454 | Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million people |
| Q28596796 | Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant? |
| Q38345525 | Strategies for reducing the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease |
| Q37612119 | Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011. |
| Q28650276 | Systems Medicine 2.0: potential benefits of combining electronic health care records with systems science models |
| Q34304455 | The double jeopardy of chronic obstructive pulmonary disease and myocardial infarction |
| Q47676572 | The role of beta-blockers in the management of chronic obstructive pulmonary disease |
| Q35802189 | Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial |
| Q31123113 | Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study |
| Q36090209 | Total joint arthroplasty and the risk of myocardial infarction: a general population, propensity score-matched cohort study |
| Q35871744 | Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study |
| Q37471531 | Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease |
| Q87970294 | Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study |
| Q87258037 | [COPD and heart disease] |
| Q36085731 | β-blocker use and mortality in COPD patients after myocardial infarction: a Swedish nationwide observational study. |
| Q64064865 | β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study |
| Q33721324 | β2-Adrenoceptor involved in smoking-induced airway mucus hypersecretion through β-arrestin-dependent signaling |
Search more.